Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease. [electronic resource]
- Alimentary pharmacology & therapeutics May 2014
- 1143-55 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1365-2036
10.1111/apt.12727 doi
Adolescent Adult Anti-Inflammatory Agents--economics Colitis, Ulcerative--drug therapy Crohn Disease--drug therapy Female Glucocorticoids--economics Health Care Costs Hospitalization--statistics & numerical data Humans Immunologic Factors--economics Male Mesalamine--economics Middle Aged Retrospective Studies Young Adult